Therapies / Cancer / Genetically Modified / Genetics / Research / Boston blog main / Boston top stories / Boulder / Denver blog main / Denver top stories / Detroit blog main / Detroit top stories / Indiana blog main / Indiana top stories / National / National blog main / National top stories / New York blog main / New York top stories / Raleigh-Durham blog main / Raleigh-Durham top stories / San Diego blog main / San Diego top stories / San Francisco blog main / San Francisco top stories / Seattle blog main / Seattle top stories / Texas blog main / Texas top stories / Wisconsin blog main / Wisconsin top stories / Acute Lymphoblastic Leukemia / Adult / andy / Biotech / Bone Marrow Transplant / CAR-T / chimeric antigen receptor T cell / Chris Williams / cure / Dean Lee / Gardner / Greta Oberhofer / JCAR015 / JCAR017 / Julie Masow / Juno Therapeutics / kid / Kymriah / Laurie Zoloth / Leukemia / Life Sciences / Maggie / Memorial Sloan-Kettering / Michael / Mike Jensen / Nationwide Children’s Hospital / Novartis / Ohio State / pediatric / Peter Bach / Rebecca Garnder / Seattle Children's Hospital / Seattle Children's Research Institute / Tim Cripe / tisagenlecleucel / young adult

On CAR-T's Edge, Seattle Researchers Plot to Bypass Novartis Therapy

Posted on: Sep 19, 2017   |   Posted by: Biotech Mag

On CAR-T's Edge, Seattle Researchers Plot to Bypass Novartis Therapy

It's not a stretch to say that Greta Oberhofer is alive thanks to the genetically modified cell therapy called CAR-T. At three and a half months old, she was diagnosed with...

Continue reading ...